about
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studiesHuman papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia.The association of pre-treatment HPV subtypes with recurrence of VIN.Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma: A Systematic Review and Meta-analysis.Gastrointestinal tract carcinoma in pediatric and adolescent age: The Italian TREP project experience.Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer.Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns.Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery.Surgical Management and Prognostic Factors of Vulvovaginal Melanoma.Medulloblastoma treatment in a child on dialysis.Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.Measuring the efficacy of a project for adolescents and young adults with cancer: A study from the Milan Youth Project.Immune Suppression and Response to Ipilimumab: Assessing Risk-to-Benefit RatioCutaneous melanoma in adolescents and young adultsImmune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanomaInvestigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experienceReorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian surveyDeveloping a score system to predict therapeutic outcomes to anti-PD-1 immunotherapy in metastatic melanomaImpact of Use of Gastric-Acid Suppressants and Oral Anti-Cancer Agents on Survival Outcomes: A Systematic Review and Meta-Analysis
P50
Q26750748-2A3ED4CD-F233-4D93-AFBE-E1F3CCAB5E3CQ36236846-758F05A9-7793-4B41-8122-E9F37EB72DA8Q36274365-70B20D86-A941-4E2B-9E9B-965076047190Q38640230-F125C52D-909A-4C5B-B9C9-786E24733F47Q38754359-AB11F40F-8D08-41D2-B2A1-0C90B5D0C8B8Q38995257-88AC2F22-A53C-46D7-83D7-1116AFDFE2FDQ39152563-375E8098-0058-4EEC-BFD3-374771416AEBQ39259845-CA29A47F-4A61-4756-A1B7-4BBD25DC72DEQ39323624-1269508E-FFB0-4B55-9B8D-3545FD253E81Q39875767-BBBEB019-D339-4B84-B548-03B9160A088CQ45810802-D02FDF89-384B-4082-9212-E4660ABEF574Q48258994-A31F73AA-B4DA-4608-AE51-B61DF189CE93Q50135525-D7B3278F-41D6-48D6-B6E9-D26071C37DA6Q87115825-8A5981F7-8D37-4F38-9DD0-B13936876755Q89401126-59B0802D-50DA-42B4-91DF-010AD112736FQ90418938-48828AE7-A4D2-48C5-A331-421278EBBDCEQ90431041-8441550A-0D20-4DB3-8987-EC5B016D6020Q92083197-7195744E-4B6E-46ED-8400-A014EC192C87Q92852423-882DD519-FC34-44FA-B697-34112BC70F7CQ93183983-4697B204-E0F0-48A2-A8AF-2760D7980D82
P50
description
researcher ORCID ID = 0000-0001-8686-4106
@en
name
Alice Indini
@ast
Alice Indini
@en
Alice Indini
@es
Alice Indini
@nl
type
label
Alice Indini
@ast
Alice Indini
@en
Alice Indini
@es
Alice Indini
@nl
prefLabel
Alice Indini
@ast
Alice Indini
@en
Alice Indini
@es
Alice Indini
@nl
P1153
55589419600
P21
P31
P496
0000-0001-8686-4106